Home › Funds › Capital Planning Advisors, LLC › ABT

Capital Planning Advisors, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Capital Planning Advisors, LLC reported holding 36,878 shares of ABT (ABBOTT LABORATORIES) in its Q1 2026 13F filing — a position valued at US$3.8M, representing 0.55% of its reported portfolio and ranking #33 among its reported holdings. Capital Planning Advisors, LLC has disclosed ABT holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)36.88K sh
Reported value held$3.79M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Capital Planning Advisors, LLC's ABT position evolved

Capital Planning Advisors, LLC first disclosed a stake in ABT in Q3 2023 at 46,486 shares (US$4.5M). The position peaked in Q2 2025 at 45,480 shares, worth US$6.2M. Across 10 filings, Capital Planning Advisors, LLC increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q1 2026) shows 36,878 shares valued at US$3.8M — a reduction of -4,468 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 46.49K $4.50M New
Q4 2023 46.48K $5.12M Hold
Q1 2024 46.04K $5.23M Reduce
Q3 2024 46.05K $5.25M Hold
Q4 2024 46.03K $5.21M Hold
Q1 2025 45.79K $6.07M Reduce
Q2 2025 45.48K $6.19M Reduce
Q3 2025 42.15K $5.64M Reduce
Q4 2025 41.35K $5.18M Reduce
Q1 2026 36.88K $3.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Capital Planning Advisors, LLC held ABT?

Capital Planning Advisors, LLC has disclosed ABT holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is Capital Planning Advisors, LLC's current position in ABT?

As of Q1 2026, Capital Planning Advisors, LLC holds 36.88K shares of ABT (ABBOTT LABORATORIES), valued at $3.79M, representing 0.55% of its reported portfolio and ranking #33.

Has Capital Planning Advisors, LLC been buying or selling ABT?

In the latest 13F filing (Q1 2026), Capital Planning Advisors, LLC reduced its position in ABT. The position peaked in Q2 2025 at 45.48K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.